≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Postprocedural endocrine and metabolic disorders, not elsewhere classified

MESH Endpoint Browser PheWeb

E4_ENDOMETPOSTOP

No definition available.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E89
Hospital discharge: ICD-9 2440|2513|2562|2572|24409
Cause of death: ICD-10 E89
Cause of death: ICD-9 2440|2513|2562|2572|24409
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 E89.4, E89.5

3 out of 7 registries used, show all original rules.

4024

diagram downward connector

Check minimum number of events None

4024

diagram downward connector

Include endpoints None

4024

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

3852

diagram downward connector
E4_ENDOMETPOSTOP

Control definitions

Control exclude E4_METABOLIA

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E70-E90
Name in latin Perturbationes endocrinae et metabolicae post interventiones non alibi classificatae

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 3852 3121 731
Unadjusted prevalence (%) 0.93 1.36 0.40
Mean age at first event (years) 52.04 51.45 54.55

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.07 3.64 [2.55, 5.18] 8.3e-13 240
15 years 0.01 1.93 [1.44, 2.58] 1.0e-5 93
5 years 0.01 4.31 [3.20, 5.79] 3.9e-22 82
1 year 0.00 8.01 [5.31, 12.09] 3.6e-23 29

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_ENDOMETPOSTOP – Postprocedural endocrine and metabolic disorders, not elsewhere classified
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Postprocedural endocrine and metabolic disorders, not elsewhere classified
after Postprocedural endocrine and metabolic disorders, not elsewhere classified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Postprocedural endocrine and metabolic disorders, not elsewhere classified

↥

Endpoint not on priority list, no data to show.